Related Experiment Video
Updated: Mar 30, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Cardiac Involvement in Von Hippel-Lindau Disease
Ernesto Valero1, Eva Rumiz, Mauricio Pellicer
1Department of Cardiology, Hospital Clx00ED;nico Universitario, Valencia, Spain.
Insights
This case report emphasizes screening for pheochromocytoma in Von Hippel-Lindau (VHL) disease patients presenting with heart failure. Early diagnosis and treatment of pheochromocytoma can improve cardiovascular outcomes in VHL patients.
Area of Science:
- Endocrinology
- Cardiology
- Oncology
Background:
- Von Hippel-Lindau (VHL) disease is a rare genetic disorder predisposing individuals to various tumors.
- Cardiovascular manifestations are not commonly associated with VHL disease.
Observation:
- A 22-year-old woman with VHL disease presented with acute decompensated heart failure.
- Echocardiography revealed a dilated left ventricle with severely reduced ejection fraction.
- Elevated urinary catecholamines and metanephrines, along with abdominal masses, indicated pheochromocytoma.
Findings:
- Surgical resection confirmed pheochromocytoma and clear cell renal carcinoma.
- Post-surgery, the patient's cardiac function significantly improved.
- Genetic analysis identified a de novo VHL gene mutation.
Implications:
- This case highlights an atypical presentation of VHL disease with significant cardiovascular impact.
- Routine screening for pheochromocytoma is crucial in VHL patients with cardiovascular symptoms.
- Prompt diagnosis and management of pheochromocytoma can lead to favorable cardiac recovery.
Objective:
The aim of this case report was to highlight the importance of ruling out pheochromocytoma in a patient with Von Hippel-Lindau disease (VHL) and cardiovascular manifestations.
Clinical Presentation And Intervention:
A 22-year-old woman with type IIb VHL presented with signs and symptoms of acute decompensated heart failure. Transthoracic echocardiography showed a dilated left ventricle with severely depressed ejection fraction, confirmed by MRI. Urinary catecholamine and metanephrine tests had elevated levels and an abdominal MRI showed the presence of two cystic masses at the left hypochondrium. Surgical resection of both masses was performed, confirming the diagnosis of pheochromocytoma and clear cell renal carcinoma on histology. Six-month echocardiography showed a left ventricle with normal diameters and preserved ejection fraction. Genetic analysis revealed a germline mutation (exon 3 deletion of VHL). As there was no family history of VHL, it was determined to be a de novo mutation.
Conclusion:
This case report showed an atypical manifestation in a patient with VHL and underlines the importance of screening for pheochromocytoma in such patients.
More Related Videos
08:22Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
08:26A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
Published on: April 12, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction